6 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Terminated 6 |
Follow Malabsorption Syndromes: new trials by email Literature Review of Malabsorption Syndromes trials Research Report on Malabsorption Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL) Ferinject, oral iron - Celiac Disease | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 1 | 2022-07-08 | 2026-07-09 |
| Budesonide in Patients With Immune Mediated Enteropathies Withdrawal of Oral Budesonide - Enteropathy, Celiac Disease | Phase 4 | Terminated | Mayo Clinic | 1 | 2019-09-10 | 2022-08-26 |
| The Use of DPP-4 Inhibitors in Short Bowel Syndrome Dipeptidyl peptidase-4 inhibitor - Short Bowel Syndrome | Phase 4 | Terminated | Stanley Dudrick's Memorial Hospital | 8 | 2016-01-01 | 2020-04-15 |
| Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion Clinolipid, Intralipid - Essential Fatty Acid Deficiency (EFAD) | Phase 4 | Terminated | Baxter Healthcare Corporation | 1 | 2015-05-01 | 2021-07-21 |
| Pancreatic Enzyme Supplementation for Celiac Disease pancrelipase - Celiac Disease | Phase 4 | Terminated | Beth Israel Deaconess Medical Center | 21 | 2015-05-01 | 2021-05-12 |
| Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS) Growth Hormone - Short Bowel Syndrome | Phase 4 | Terminated | University of Nebraska | 5 | 2003-09-01 | 2023-09-08 |
Celiac Disease (3) · Short Bowel Syndrome (3) · Hyperphagia (2) · Autoimmune enteropathy (1) · Collagenous Sprue (1) · Intestinal Diseases (1) · Iron Deficiencies (1) · Pena Shokeir syndrome, type 1 (1)
Digestive System Diseases (6) · Gastrointestinal Diseases (6) · Intestinal Diseases (5) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Postoperative Complications (3) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Iron Metabolism Disorders (1)
Amylases (1) · Dipeptidyl-Peptidase IV Inhibitors (1) · Growth Hormone (1) · Iron (1) · Lipase (1) · Pancrelipase (1) · Peptide Hydrolases (1) · Sitagliptin Phosphate (1) · WW Domain-Containing Oxidoreductase (1) · ferric carboxymaltose (1) · soybean oil, phospholipid emulsion (1)
Assistance Publique - Hôpitaux de Paris (1) · Baxter Healthcare Corporation (1) · Beth Israel Deaconess Medical Center (1) · Mayo Clinic (1) · Stanley Dudrick's Memorial Hospital (1) · University of Nebraska (1)
United States (4) · France (1) · Poland (1)
Ciaran Kelly, MD (1) · Fedja Rochling, MB, ChB (1) · Joseph A Murray, MD (1)
2019 (1)